Arimidex With or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer (PACT001)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2014 by Baylor Breast Care Center
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Baylor Breast Care Center
ClinicalTrials.gov Identifier:
NCT00570323
First received: December 6, 2007
Last updated: May 14, 2014
Last verified: May 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2016
  Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)